The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities

por Chilton, L, Hills, R K, Burnett, A K, Harrison, C J
Publicado 2016

Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3(+) regulatory T cells

por Coles, S J, Hills, R K, Wang, E C Y, Burnett, A K, Man, S, Darley, R L, Tonks, A
Publicado 2012

Expression of CD200 on AML blasts directly suppresses memory T-cell function

por Coles, S J, Hills, R K, Wang, E C Y, Burnett, A K, Man, S, Darley, R L, Tonks, A
Publicado 2012

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

por Burnett, A K, Hills, R K, Nielsen, O J, Freeman, S, Ali, A, Cahalin, P, Hunter, A, Thomas, I F, Russell, N H
Publicado 2018

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia

por Burnett, A K, Russell, N H, Hills, R K, Kell, J, Nielsen, O J, Dennis, M, Cahalin, P, Pocock, C, Ali, S, Burns, S, Freeman, S, Milligan, D, Clark, R E
Publicado 2017